Koc University Digital Collections
metadata only
Derivation and validation of a new Still activity score (SAS)
Roche; UCB; Novartis; Pfizer; MSD; Abbvie; Amgen
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Validity and Reliability of the 6-minute Walk Test Over a Distance of 6 Metres in People With Multiple Sclerosis#979990
- Comparing Stopping or Continuing Use of Disease-Modifying Therapies in Older Adults with Multiple Sclerosis—The DISCOMS Trial#1997
- Rehabilitation in Multiple Sclerosis - Sometimes Too Much?#1102530
- CliffRank: A Dual-Branch Framework for Activity-Cliff Ranking Prediction#822109
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TB-840 in Healthy Subjects#1100642
Record · ID 955624
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive